… % of global COVID-19 clinical trials are testing combination therapies, with the majority
exploring dual combinations. As of 29 March 2021, there are 26 dual combination pivotal trials, of …

… the treatment of advanced stage of COVID-19 and the reduction of mechanical ventilators …
the role of combination therapy with tocilizumab and steroids in COVID-19 patients. Relevant …

… be noted with caution in COVID-19. Most reports concerning COVID-19 non-survivors have
… may be an option to assess the prognosis of COVID-19. Tang et al reported that heparin (…

… on co-infection among patients with coronavirus disease 2019 (COVID-19). The prevalence
of co-infection was variable among COVID-19 patients in different studies, however, it could …

… In our cohort of 144 mainly immunocompromised patients receiving first-line combination
therapies for COVID-19, clinical courses were mild to moderate and prolonged viral shedding …

… Our findings demonstrates that therapy with a combination of aprotinin with Avifavir ® … in
patients hospitalized with COVID-19-associated pneumonia and requiring oxygen therapy, as …

… efficacy of potential therapies for COVID-19 is through studying combination therapies, ideally
with … the development of repurposed drugs as combination therapies to treat COVID-19. …

… pinpoint and prioritize optimal combination therapies against COVID-19 by pairing a … 50
combination regimens at three dosing levels per drug, representing 729 possible combinations. …

… ALI, studies addressing the effect of a planned combination therapy are warranted. Thus, in
… COVID-19 pneumonia who developed ALI. The patients in addition to the supportive therapy …

… We proposed combination therapy using current COVID-19 repurposed drugs. … Although
combination therapy involving two or more of the current and potential COVID-19 agents could …